(Q41357228)

29 September 2017

title

In vitro tumor necrosis factor cytotoxicity in Hep G2 liver cells (English)

1 reference

29 September 2017

Hill DB

1

1 reference

29 September 2017

Schmidt J

2

1 reference

29 September 2017

Shedlofsky SI

3

1 reference

29 September 2017

Cohen DA

4

1 reference

29 September 2017

McClain CJ

5

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 April 1995

1 reference

29 September 2017

1 reference

29 September 2017

volume

21

1 reference

29 September 2017

issue

4

1 reference

29 September 2017

page(s)

1114-1119

1 reference

Enhanced tumor necrosis factor and interleukin-1 in an experimental model of massive liver cell necrosis/fatal hepatitis in mice

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Involvement of tumor necrosis factor-alpha in development of hepatic injury in galactosamine-sensitized mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Involvement of tumor necrosis factor-alpha in the pathogenesis of activated macrophage-mediated hepatitis in mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Does tumor necrosis factor play a role in the pathogenesis of fulminant hepatitis?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Increased tumor necrosis factor production by monocytes in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Tumor necrosis factor, the acute phase response and the pathogenesis of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Increased plasma tumor necrosis factor in severe alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Cytokines and alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Microsomal induction, alcohol, and lipoprotein metabolism: is there a three-way relationship?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Regulation of squalene synthetase in human hepatoma cell line Hep G2 by sterols, and not by mevalonate-derived non-sterols

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Interleukin 1 and tumour necrosis factor increase phosphorylation of the small heat shock protein. Effects in fibroblasts, Hep G2 and U937 cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Interferon beta 2/B-cell stimulating factor 2/interleukin 6 affects glycosylation of acute phase proteins in human hepatoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Interleukin-6 enhances the expression of tumor necrosis factor receptors on hepatoma cells and hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Serum-free in vitro bioassay for the detection of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Comparison of in vitro cell cytotoxic assays for tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Ca2+ influx via T-type channels modulates PDGF-induced replication of mouse fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Novel tumor necrosis factor toxic effects. Pulmonary hemorrhage and severe hepatic dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Transforming growth factor-beta in disease: the dark side of tissue repair

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

The acute-phase response protects mice from D-galactosamine sensitization to endotoxin and tumor necrosis factor–α

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840210434

7 January 2021

Identifiers

DOI

10.1002/HEP.1840210434

1 reference

29 September 2017

1 reference